Preserving Patient Access to Home Infusion Act
- Bill Number
- S. 1058
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-03-13: Read twice and referred to the Committee on Finance.
- Last Updated
- 2026-03-09T20:28:21Z
AI-Generated Summary
Purpose of the Legislation
The Preserving Patient Access to Home Infusion Act (S. 1058) aims to clarify Congress's original intent and ensure Medicare beneficiaries continue to have reliable access to home infusion therapy. Home infusion therapy involves delivering medications like antibiotics or antivirals directly into a patient's bloodstream at home, rather than in a hospital or clinic. The bill addresses gaps in current Medicare rules to make this care more accessible and efficiently paid for.
Key Provisions
- Inclusion of Pharmacy Services: Expands the definition of home infusion therapy to explicitly include pharmacy services, such as drug preparation, compounding (mixing medications), assessments, and coordination of care in the patient's treatment plan.
- Payment Adjustments:
- Updates Medicare's payment system for home infusion to cover each day a drug is administered, even if the supplier (like a pharmacy or nurse) is not physically present at the home.
- Introduces a transitional payment rule from 2026 to 2029, ensuring payments reflect about 5 hours of infusion time per day for specific therapies.
- Applies a 50% reduced payment on days when the supplier is not physically present during administration.
- Expanded Provider Roles: Allows nurse practitioners (advanced practice nurses) and physician assistants (mid-level providers who assist doctors) to create and review home infusion care plans, in addition to physicians.
- Coverage for Non-Pump Drugs: Broadens Medicare coverage to include certain intravenous (IV) drugs and biologicals (like medications derived from living organisms) that do not require a pump device. These are limited to antibacterial, antifungal, or antiviral drugs, as classified by the United States Pharmacopeia (a standard-setting organization for medicines).
- Billing Clarification for Non-Pump Drugs: Ensures suppliers can bill Medicare for related services (like nursing or pharmacy support) even if the drug itself is not separately payable under Medicare Part B (outpatient coverage).
- Payment Rules for Supplies: Prohibits separate Medicare payments for certain durable medical equipment (DME) supplies—such as tubing, catheters, dressings, needles, syringes, and related items (identified by specific billing codes)—if they are used on the same day as paid home infusion therapy for the same drug. This prevents duplicate billing.
- Effective Date: All changes apply to services provided on or after January 1, 2026.
Significant Changes to Existing Law
- Definition Expansions: Current Medicare law (under the Social Security Act, Title XVIII) limits home infusion to services involving pumps as DME. This bill adds pharmacy roles and non-pump IV drugs, making coverage more inclusive.
- Payment Reforms: Shifts from rigid presence-based payments to day-of-administration models, with reductions for remote delivery. It also introduces time-based transitional payments and blocks double payments for supplies, which were previously allowed under DME rules.
- Provider Flexibility: Previously, only physicians could establish and review care plans; now, nurse practitioners and physician assistants are included, reducing reliance on doctors and potentially speeding up care initiation.
These amendments build on the 21st Century Cures Act (2016), which first established temporary home infusion benefits, by making them more permanent and practical.
Potential Impacts
- On Citizens (Medicare Beneficiaries): Improves access to convenient, at-home treatment for chronic conditions requiring IV medications, potentially reducing hospital visits, travel burdens, and infection risks. This could lower out-of-pocket costs by streamlining coverage, especially for rural or mobility-limited patients.
- On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) will need to update payment systems, billing codes, and guidelines, which may increase short-term administrative workload but aim to reduce overall program costs by avoiding duplicate payments (potentially saving millions in federal spending).
- On International Relations: No direct impacts; this is a domestic healthcare policy focused on U.S. Medicare.
- Broader Effects: Encourages shift from facility-based to home-based care, aligning with trends in telemedicine and cost containment, but could strain supplier capacity if demand rises without adequate reimbursement.
Main Stakeholders Affected
- Medicare Patients: Primary beneficiaries, especially those with infections or immune conditions needing long-term IV therapy.
- Home Infusion Suppliers and Pharmacies: Qualified providers (e.g., specialty pharmacies) gain clearer billing rules and expanded services but face reduced payments for remote or supply-inclusive days.
- Healthcare Providers: Physicians, nurse practitioners, and physician assistants benefit from shared responsibilities in care planning.
- Suppliers of Medical Supplies: Companies providing DME items like tubing may see reduced Medicare revenue due to bundled payments.
- CMS and Federal Budget: Oversees implementation; taxpayers indirectly affected through Medicare expenditures.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: Strengthens Medicare's statutory framework by resolving ambiguities in prior laws, reducing potential disputes over coverage denials. It promotes equity in healthcare delivery without altering core Medicare eligibility (for those 65+ or disabled).
- Constitutional Implications: None significant; the bill operates within Congress's authority under the Spending Clause (Article I, Section 8) to regulate federal programs like Medicare. It avoids equal protection issues by applying uniformly to all eligible beneficiaries.
- Political Implications: Bipartisan support (introduced by Sens. Warner (D-VA) and Scott (R-SC)) reflects priorities in aging populations and home health expansion post-COVID. It could influence future healthcare debates on cost control versus access, potentially serving as a model for expanding telehealth or non-physician roles in other programs. No major controversies anticipated, as it focuses on clarification rather than new entitlements.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-03-13: Read twice and referred to the Committee on Finance.
- 2025-03-13: Introduced in Senate
Bill Versions
- Preserving Patient Access to Home Infusion Act — issued 2025-03-13 — PDF (7 pages)